10-117543388-T-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The NM_004098.4(EMX2):āc.121T>Gā(p.Ser41Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000424 in 1,580,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_004098.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EMX2 | NM_004098.4 | c.121T>G | p.Ser41Ala | missense_variant | 1/3 | ENST00000553456.5 | NP_004089.1 | |
EMX2 | NM_001165924.2 | c.121T>G | p.Ser41Ala | missense_variant | 1/2 | NP_001159396.1 | ||
EMX2OS | NR_002791.2 | n.574+918A>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EMX2 | ENST00000553456.5 | c.121T>G | p.Ser41Ala | missense_variant | 1/3 | 1 | NM_004098.4 | ENSP00000450962.3 | ||
EMX2OS | ENST00000551288.5 | n.574+918A>C | intron_variant | 1 | ||||||
EMX2 | ENST00000442245.5 | c.121T>G | p.Ser41Ala | missense_variant | 1/2 | 2 | ENSP00000474874.1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 151766Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000526 AC: 10AN: 190058Hom.: 0 AF XY: 0.0000193 AC XY: 2AN XY: 103360
GnomAD4 exome AF: 0.0000273 AC: 39AN: 1429094Hom.: 0 Cov.: 32 AF XY: 0.0000212 AC XY: 15AN XY: 708048
GnomAD4 genome AF: 0.000184 AC: 28AN: 151880Hom.: 0 Cov.: 29 AF XY: 0.000121 AC XY: 9AN XY: 74252
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at